Trademark: 97451246
Word
ELENAE THERAPEUTICS
Status Date
Thursday, December 14, 2023
Filing Date
Thursday, June 9, 2022
Published for Opposition
Tuesday, May 2, 2023
5 Medical therapeutic preparations, namely, antisense therapeutics; therapeutics in the nature of pharmaceuticals for treatment of Duchenne Muscular Dystrophy (DMD)
42 research and development of gene therapeutics, namely, antisense therapeutics; research and development of anti-miRNA technology for the treatment of Duchenne Muscular Dystrophy (DMD); research and development of therapeutics for treatment of Duchenne Muscular Dystrophy (DMD); pharmaceutical and therapeutic research and development
Jun 13, 2022
New Application Entered
Jun 22, 2022
New Application Office Supplied Data Entered
Mar 23, 2023
Assigned To Examiner
Mar 27, 2023
Examiners Amendment -Written
Mar 27, 2023
Examiners Amendment E-Mailed
Mar 27, 2023
Notification Of Examiners Amendment E-Mailed
Mar 27, 2023
Examiner's Amendment Entered
Mar 27, 2023
Approved For Pub - Principal Register
Apr 12, 2023
Notification Of Notice Of Publication E-Mailed
May 2, 2023
Official Gazette Publication Confirmation E-Mailed
May 2, 2023
Published For Opposition
Dec 14, 2023
Sou Extension 1 Filed
Jun 27, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 14, 2023
Sou Teas Extension Received
Dec 14, 2023
Sou Extension 1 Granted
Apr 23, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 23, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 23, 2024
Teas Change Of Correspondence Received
Dec 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
